Claudia Oddi

894 total citations
6 papers, 713 citations indexed

About

Claudia Oddi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Claudia Oddi has authored 6 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Claudia Oddi's work include Cardiac Fibrosis and Remodeling (4 papers), Signaling Pathways in Disease (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Claudia Oddi is often cited by papers focused on Cardiac Fibrosis and Remodeling (4 papers), Signaling Pathways in Disease (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Claudia Oddi collaborates with scholars based in United States and Italy. Claudia Oddi's co-authors include Benjamín W. Van Tassell, Charles A. Dinarello, Nayef Abouzaki, Antonio Abbate, Giuseppe Biondi‐Zoccai, Michael C. Kontos, Norbert F. Voelkel, Ryan Melchior, Michael Gambill and George W. Vetrovec and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Molecular Medicine.

In The Last Decade

Claudia Oddi

6 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Oddi United States 5 422 347 182 157 111 6 713
Ryan Melchior United States 7 351 0.8× 378 1.1× 232 1.3× 163 1.0× 124 1.1× 9 708
Michael Gambill United States 4 246 0.6× 278 0.8× 151 0.8× 123 0.8× 97 0.9× 5 493
Roshanak Robati United States 5 296 0.7× 315 0.9× 137 0.8× 142 0.9× 86 0.8× 6 535
George Mueller United States 3 233 0.6× 260 0.7× 145 0.8× 117 0.7× 92 0.8× 5 453
Kotaro Naito Japan 14 409 1.0× 260 0.7× 156 0.9× 138 0.9× 70 0.6× 18 720
Nayef Abouzaki United States 13 816 1.9× 530 1.5× 259 1.4× 246 1.6× 174 1.6× 19 1.3k
Sanah Christopher United States 9 227 0.5× 201 0.6× 102 0.6× 93 0.6× 87 0.8× 11 452
Cord Manhenke Norway 14 551 1.3× 162 0.5× 97 0.5× 205 1.3× 51 0.5× 19 764
Claire Foley United Kingdom 8 205 0.5× 279 0.8× 176 1.0× 166 1.1× 142 1.3× 13 753
Ola Kleveland Norway 9 200 0.5× 201 0.6× 229 1.3× 106 0.7× 131 1.2× 15 498

Countries citing papers authored by Claudia Oddi

Since Specialization
Citations

This map shows the geographic impact of Claudia Oddi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Oddi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Oddi more than expected).

Fields of papers citing papers by Claudia Oddi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Oddi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Oddi. The network helps show where Claudia Oddi may publish in the future.

Co-authorship network of co-authors of Claudia Oddi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Oddi. A scholar is included among the top collaborators of Claudia Oddi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Oddi. Claudia Oddi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Abbate, Antonio, Michael C. Kontos, Nayef Abouzaki, et al.. (2014). Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies). The American Journal of Cardiology. 115(3). 288–292. 132 indexed citations
2.
Sonnino, Chiara, Sanah Christopher, Claudia Oddi, et al.. (2014). Leukocyte Activity in Patients with ST-Segment Elevation Acute Myocardial Infarction Treated with Anakinra. Molecular Medicine. 20(1). 486–489. 12 indexed citations
3.
Abbate, Antonio, Benjamín W. Van Tassell, Sanah Christopher, et al.. (2014). Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction (from the VCU-Alpha 1-RT Pilot Study). The American Journal of Cardiology. 115(1). 8–12. 41 indexed citations
4.
Abbate, Antonio, Benjamín Van Tassell, Giuseppe Biondi‐Zoccai, et al.. (2013). INTERLEUKIN-1 BLOCKADE WITH ANAKINRA TO PREVENT ADVERSE CARDIAC REMODELING FOLLOWING ACUTE MYOCARDIAL INFARCTION: RESULTS OF THE VCU-ART2 PILOT STUDY. Journal of the American College of Cardiology. 61(10). E179–E179. 1 indexed citations
5.
Abbate, Antonio, Benjamín W. Van Tassell, Giuseppe Biondi‐Zoccai, et al.. (2013). Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]. The American Journal of Cardiology. 111(10). 1394–1400. 307 indexed citations
6.
Tassell, Benjamín W. Van, Ross Arena, Giuseppe Biondi‐Zoccai, et al.. (2013). Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study). The American Journal of Cardiology. 113(2). 321–327. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026